Quality of T2-weighted MRI re-acquisition versus deep learning GAN image reconstruction: A multi-reader study.

Artificial Intelligence Diagnostic Imaging Generative Adversarial Networks Image Quality Magnetic Resonance Imaging

Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 01 10 2023
revised: 23 11 2023
accepted: 07 12 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

To evaluate CycleGAN's ability to enhance T2-weighted image (T2WI) quality. A CycleGAN algorithm was used to enhance T2WI quality. 96 patients (192 scans) were identified from patients who underwent multiple axial T2WI due to poor quality on the first attempt (RAD1) and improved quality on re-acquisition (RAD2). CycleGAN algorithm gave DL classifier scores (0-1) for quality quantification and produced enhanced versions of QI1 and QI2 from RAD1 and RAD2, respectively. A subset (n = 20 patients) was selected for a blinded, multi-reader study, where four radiologists rated T2WI on a scale of 1-4 for quality. The multi-reader study presented readers with 60 image pairs (RAD1 vs RAD2, RAD1 vs QI1, and RAD2 vs QI2), allowing for selecting sequence preferences and quantifying the quality changes. The DL classifier correctly discerned 71.9 % of quality classes, with 90.6 % (96/106) as poor quality and 48.8 % (42/86) as diagnostic in original sequences (RAD1, RAD2). CycleGAN images (QI1, QI2) demonstrated quantitative improvements, with consistently higher DL classifier scores than original scans (p < 0.001). In the multi-reader analysis, CycleGAN demonstrated no qualitative improvements, with diminished overall quality and motion in QI2 in most patients compared to RAD2, with noise levels remaining similar (8/20). No readers preferred QI2 to RAD2 for diagnosis. Despite quantitative enhancements with CycleGAN, there was no qualitative boost in T2WI diagnostic quality, noise, or motion. Expert radiologists didn't favor CycleGAN images over standard scans, highlighting the divide between quantitative and qualitative metrics.

Identifiants

pubmed: 38128256
pii: S0720-048X(23)00573-9
doi: 10.1016/j.ejrad.2023.111259
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111259

Informations de copyright

Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mason J Belue (MJ)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Stephanie A Harmon (SA)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Samira Masoudi (S)

University of California San Diego, San Diego, CA, USA.

Tristan Barrett (T)

Department of Radiology, University of Cambridge, Cambridge, England.

Yan Mee Law (YM)

Department of Radiology, Singapore General Hospital, Singapore.

Andrei S Purysko (AS)

Section of Abdominal Imaging, Imaging Institute, Cleveland Clinic, Cleveland, OH, USA.

Valeria Panebianco (V)

Department of Radiology, Sapienza University of Rome, Rome, Italy.

Enis C Yilmaz (EC)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Yue Lin (Y)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Pavan Kumar Jadda (PK)

Center for Information Technology, National Institutes of Health, Bethesda, MD, USA.

Sitarama Raavi (S)

Center for Information Technology, National Institutes of Health, Bethesda, MD, USA.

Bradford J Wood (BJ)

Center for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD, USA; Department of Radiology, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Peter A Pinto (PA)

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Peter L Choyke (PL)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Baris Turkbey (B)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: turkbeyi@mail.nih.gov.

Classifications MeSH